Literature DB >> 26225856

Seizure Outcomes in Patients With Surgically Treated Cerebral Arteriovenous Malformations.

Christian von der Brelie1, Matthias Simon, Jonas Esche, Johannes Schramm, Azize Boström.   

Abstract

BACKGROUND: Epilepsy is the second most common symptom in cerebral arteriovenous malformation (AVM) patients. The consecutive reduction of life quality is a clinically underrated problem because treatment usually focuses on the prevention of intracerebral hemorrhage.
OBJECTIVE: To evaluate postoperative seizure outcome with the aim of more accurate counseling for postoperative seizure outcome.
METHODS: From 1985 to 2012, 293 patients with an AVM were surgically treated by J.S. One hundred twenty-six patients with preoperative seizures or epilepsy could be identified; 103 of 126 had a follow-up of at least 12 months and were included in the analysis. The different epilepsy subtypes were categorized (sporadic seizures, chronic epilepsy, drug-resistant epilepsy [DRE]). Preoperative workup and surgical technique were evaluated. Seizure outcome was analyzed by using International League Against Epilepsy classification.
RESULTS: Sporadic seizures were identified in 41% of patients (chronic epilepsy and DRE were identified in 36% and 23%, respectively). Detailed preoperative epileptological workup was done in 13%. Seizure freedom was achieved in 77% (79% at 5 years, 84% at 10 years). Outcome was significantly poorer in DRE cases. More extensive resection was performed in 11 cases with longstanding symptoms (>24 months) and resulted in better seizure outcome as well as the short duration of preoperative seizure history.
CONCLUSION: Patients presenting with AVM-associated epilepsy have a favorable seizure outcome after surgical treatment. Long-standing epilepsy and the progress into DRE markedly deteriorate the chances to obtain seizure freedom and should be considered an early factor in establishing the indication for AVM removal.

Entities:  

Mesh:

Year:  2015        PMID: 26225856     DOI: 10.1227/NEU.0000000000000919

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

1.  Seizure predictors and outcome after Onyx embolization in patients with brain arteriovenous malformations.

Authors:  Baorui Zhang; Xin Feng; Fei Peng; Luyao Wang; Er Kang Guo; Yupeng Zhang; Peng Liu; Zhongxue Wu; Aihua Liu
Journal:  Interv Neuroradiol       Date:  2018-09-30       Impact factor: 1.610

2.  Seizure control following treatment of brain arteriovenous malformations in pediatric patients.

Authors:  Xiangke Ma; Xianzeng Tong; Jun Wu; Yong Cao; Shuo Wang
Journal:  Childs Nerv Syst       Date:  2016-09-01       Impact factor: 1.475

Review 3.  Complete seizure-free rates following interventional treatment of intracranial arteriovenous malformations: a systematic review and meta-analysis.

Authors:  James C Mamaril-Davis; Pedro Aguilar-Salinas; Mauricio J Avila; Peter Nakaji; Robert W Bina
Journal:  Neurosurg Rev       Date:  2022-01-06       Impact factor: 3.042

4.  Incidence and risk factors of epilepsy following brain arteriovenous malformation rupture in adult patients.

Authors:  Gonzague Guillaumet; Eimad Shotar; Frédéric Clarençon; Nader-Antoine Sourour; Kevin Premat; Stéphanie Lenck; Sophie Dupont; Alice Jacquens; Vincent Degos; Tom Boeken; Aurélien Nouet; Alexandre Carpentier; Bertrand Mathon
Journal:  J Neurol       Date:  2022-07-22       Impact factor: 6.682

5.  Intracranial Gorgon: Surgical Case Report of a Large Calcified Brain Arteriovenous Malformation.

Authors:  Ioan Alexandru Florian; Laura Popovici; Teodora Larisa Timis; Ioan Stefan Florian; Ioana Berindan-Neagoe
Journal:  Am J Case Rep       Date:  2020-04-28

6.  Histopathology of brain AVMs part I: microhemorrhages and changes in the nidal vessels.

Authors:  Patrik Järvelin; Roosa Wright; Henri Pekonen; Sara Keränen; Tuomas Rauramaa; Juhana Frösen
Journal:  Acta Neurochir (Wien)       Date:  2020-05-12       Impact factor: 2.216

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.